We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Image of Sarah Whelan, PhD

Sarah Whelan, PhD

Science Writer

Contact Us


Sarah joined Technology Networks in May 2022 after completing a master’s degree in biochemistry from the University of Kent and a PhD in cancer biology from the University of Leicester, where her research focused on the development of colon cancers. In her role as a science writer and editor, Sarah covers scientific news and a range of other scientific content for the site.


Latest Content
Illustration of a DNA strand breaking apart.
News

Tracing the Mutation Trail of Breast Cancers

Breast cancer is one of the most common cancer types, with 2.3 million women diagnosed with breast cancer worldwide in 2020, and a new study has uncovered process of mutations that lead to some breast cancers.
Computer-generated image of cancer cells.
News

Cancer Cases Surge in Under 50s Over the Last 3 Decades

New cases of early-onset cancers in the under 50s have risen by 79% globally over the past three decades, suggests a new study published in BMJ Oncology.
Tumor Heterogeneity
Infographic

Tumor Heterogeneity

Download this infographic to learn more about the types of tumor heterogeneity, why heterogeneity can affect cancer treatment and how heterogeneity is linked to treatment resistance.
A psychedelic haze.
Industry Insight

Exploring the LSD-Derivative With Potential for Treating Mood Disorders

BetterLife Pharma’s lead candidate is a non-hallucinogenic derivative of LSD that mimics the projected therapeutic properties of LSD. To learn more, we spoke with BetterLife Pharma’s chief operating officer, Dr. Hooshmand Sheshbaradaran, and head of preclinical research, Dr. Abdi Ghaffari.
Illustration of a tumor.
News

Brain Tumor Gene Therapy Shows Early Promise in First-in-Human Trial

Combination drug and immunotherapy treatment can extend survival in patients with gliomas, a highly aggressive form of brain cancer, suggests a new Phase 1, first-in-human trial.
Computer-generated image of cancer cells.
News

Cancer Drug “Envelope” Protects Against Heart-Damaging Side Effects

Researchers have developed a protein “envelope” that surrounds the cancer drug doxorubicin, both increasing its chances of being taken up by cancer cells and decreasing its toxic effects on lab-grown heart cells.
An anatomical model of a human heart.
News

Sex-Specific Symptoms Experienced Before a Sudden Cardiac Arrest

People who experience a sudden cardiac arrest can also experience sex-specific symptoms in the hours before the event, such as shortness of breath for women and chest pain for men, according to a new study.
A collection of pills.
News

Phytosterol Supplement Reduces Hearing Loss in Mice

A new study in mice has shown that phytosterol, a common dietary supplement, may help to reduce age-related hearing loss.
A person wearing gloves drawing a vaccine up from a vial into a syringe.
News

Maternal Vaccine To Protect Infants Against RSV From Birth Approved by FDA

The FDA has approved the first vaccine against respiratory syncytial virus (RSV), designed for use during pregnancy to protect infants from severe RSV-associated respiratory disease in their first six months of life.
A hand grasping a molecule, showing how clovibactin can tightly wrap around special lipids in bacterial cell membranes.
News

Resistant Superbugs Killed by New Antibiotic From Bacterial “Dark Matter”

A study has isolated a powerful new antibiotic – clovibactin – from soil bacteria previously considered “unculturable”, demonstrating that it kills bacteria in a way that is less likely to lead to antibiotic resistance.
Advertisement